Complete arterial revascularization in triple-vessel coronary disease

Akinci E., Guler M., BOZBUĞA N., Kutay V., Daglar B., Gurbuz A., ...More

Cor Europaeum - European Journal of Cardiac Interventions, vol.8, no.1, pp.19-23, 1999 (Scopus) identifier

  • Publication Type: Article / Article
  • Volume: 8 Issue: 1
  • Publication Date: 1999
  • Journal Name: Cor Europaeum - European Journal of Cardiac Interventions
  • Journal Indexes: Scopus
  • Page Numbers: pp.19-23
  • Keywords: Arterial grafts, Complete arterial revascularization, Full arterial CABG, Triple vessel disease
  • Istanbul University Affiliated: Yes


Complete arterial revascularization has become a favoured form of surgical treatment for multivessel coronary artery disease because of the excellent long-term patency of the internal thoracic artery. From September 1994 to September 1997, complete arterial revascularization was performed on 72 patients (69 male and 3 female) with triple-vessel coronary disease, aged 46.4 ± 6.3 years. Both the internal thoracic arteries and right gastroepiploic artery were used in all patients. The inferior epigastric artery and radial artery were selected as a fourth arterial graft in 21 patients, 33 patients (45.8%) had stable angina pectoris and 39 patients had unstable angina pectoris (54.2%). The mean preoperative left ventricular ejection fraction was 0.41 ± 0.14 (ranged 0.30 to 0.60). There were 237 coronary artery grafts (mean 3.3 per patient). The operative mortality rate was 4.2% and the early morbidity rate was 9.7%. The surviving patients (95.8%) were followed up for 10 to 46 months, with a mean of 22.4 ± 1.6 months. The total follow-up period was 126.9 patient years. Complete arterial revascularization can be performed safely for the treatment of multivessel coronary artery disease and this procedure may become a routine technique in coronary bypass surgery, providing excellent late results.